Debu Tripathy

Debu Tripathy

UNVERIFIED PROFILE

Are you Debu Tripathy?   Register this Author

Register author
Debu Tripathy

Debu Tripathy

Publications by authors named "Debu Tripathy"

Are you Debu Tripathy?   Register this Author

100Publications

2916Reads

5Profile Views

Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype.

Br J Cancer 2020 Aug 4. Epub 2020 Aug 4.

Department of Anatomical Pathology, Section of Neuropathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-020-1008-2DOI Listing
August 2020

The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.

Breast Cancer Res Treat 2020 Jul 27. Epub 2020 Jul 27.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05837-6DOI Listing
July 2020

Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.

Oncologist 2019 10 5;24(10):1322-1330. Epub 2019 Apr 5.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2018-0713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795167PMC
October 2019

HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological features.

Hum Pathol 2019 10 24;92:32-38. Epub 2019 Jul 24.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2019.07.006DOI Listing
October 2019

Ribociclib and Endocrine Therapy in Breast Cancer. Reply.

N Engl J Med 2019 10;381(16):1592-1593

University of Texas M.D. Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1911188DOI Listing
October 2019

Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and/or ado-trastuzumab emtansine (T-DM1).

Breast Cancer Res Treat 2019 Jul 11;176(1):227-234. Epub 2019 Apr 11.

Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05081-zDOI Listing
July 2019

Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.

Breast Cancer Res Treat 2019 Jul;176(1):251

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05218-8DOI Listing
July 2019

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.

N Engl J Med 2019 07 4;381(4):307-316. Epub 2019 Jun 4.

From Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), the Yonsei Cancer Center, Yonsei University Health System (J.S.), and the Asan Medical Center, University of Ulsan College of Medicine (K.-H.J.), Seoul, and the Center for Breast Cancer, National Cancer Center, Gyeonggi-do (K.-S.L.) - all in South Korea; National Taiwan University Hospital, Taipei, Taiwan (Y.-S.L.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (A.B.); the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany (N.H.); the Division of Medical Senology, Istituto Europeo di Oncologia, Milan (M.C.); Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil (F.F.); the Organisation for Oncology and Translational Research, Hong Kong (L.C.); Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico (S.C.-G.); Institut Català d'Oncologia, Hospital de Sant Joan Despí Moisès Broggi, Barcelona (R.V.-V.); Novartis Pharmaceuticals, East Hanover, NJ (A.C., K.R.-L., T.T.); Novartis, Basel, Switzerland (G.H., I.G.); the UCLA Jonsson Comprehensive Cancer Center, Los Angeles (S.H.); and the University of Texas M.D. Anderson Cancer Center, Houston (D.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903765DOI Listing
July 2019

Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.

Breast Cancer Res Treat 2019 Jun 2;175(2):339-351. Epub 2019 Mar 2.

Section of Translational Breast Cancer Research, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05166-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534477PMC
June 2019

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.

J Cancer 2019 2;10(12):2635-2642. Epub 2019 Jun 2.

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.32453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584927PMC
June 2019

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.

Breast Cancer Res Treat 2019 May 22;175(1):5-15. Epub 2019 Jan 22.

City of Hope Medical Group, Inc, 1500 E Duarte Rd, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05102-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491395PMC
May 2019

Clinical findings and outcomes of MRI staging of breast cancer in a diverse population.

Breast Cancer Res Treat 2019 Apr 12;174(2):315-324. Epub 2018 Dec 12.

Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05084-wDOI Listing
April 2019

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer.

Cancers (Basel) 2018 Dec 19;10(12). Epub 2018 Dec 19.

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10120525DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315782PMC
December 2018

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.

Breast Cancer Res Treat 2018 Sep 18;171(2):501-511. Epub 2018 Jun 18.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4853-4DOI Listing
September 2018

RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.

Ann Surg Oncol 2018 Aug 4;25(8):2261-2270. Epub 2018 Jun 4.

Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6540-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065419PMC
August 2018

Reply to E. Parkin et al.

J Clin Oncol 2018 07 30;36(20):2129-2130. Epub 2018 May 30.

Christina M. Dieli-Conwright, University of Southern California Los Angeles, CA; Kerry S. Courneya, University of Alberta, Edmonton, Alberta, Canada; Wendy Demark-Wahnefried, University of Alabama at Birmingham, Birmingham, AL; Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, and Darcy Spicer, University of Southern California Los Angeles, CA; Debu Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; and Leslie Bernstein and Joanne E. Mortimer, City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.7754DOI Listing
July 2018

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Cancer 2018 06 26;124(11):2299-2305. Epub 2018 Mar 26.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31336DOI Listing
June 2018

How Does MR Imaging Help Care for the Breast Cancer Patient? Perspective of a Medical Oncologist.

Magn Reson Imaging Clin N Am 2018 May 21;26(2):289-293. Epub 2018 Feb 21.

Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mric.2017.12.013DOI Listing
May 2018

Risk factors for falls in older patients with cancer.

BMJ Support Palliat Care 2018 Mar 31;8(1):34-37. Epub 2017 Aug 31.

Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2017-001388DOI Listing
March 2018

Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial.

J Clin Oncol 2018 03 22;36(9):875-883. Epub 2018 Jan 22.

Christina M. Dieli-Conwright, Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, and Darcy V. Spicer, University of Southern California, Los Angeles; Leslie Bernstein and Joanne E. Mortimer, City of Hope, Duarte, CA; Kerry S. Courneya, University of Alberta, Edmonton, Alberta, Canada; Wendy Demark-Wahnefried, University of Alabama at Birmingham, Birmingham, AL; and Debu Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.7526DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858524PMC
March 2018

Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.

Clin Breast Cancer 2018 02 9;18(1):e7-e13. Epub 2017 Nov 9.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15268209173062
Publisher Site
http://dx.doi.org/10.1016/j.clbc.2017.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937690PMC
February 2018

Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer.

Eur J Cancer 2018 01 9;89:64-71. Epub 2017 Dec 9.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.11.015DOI Listing
January 2018

Mechanism of Action and Clinical Impact of Ribociclib-Response.

Clin Cancer Res 2017 09;23(18):5658

The Broad Institute and Dana-Farber Cancer Institute, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1819DOI Listing
September 2017

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes.

Oncotarget 2017 Sep 31;8(41):70481-70495. Epub 2017 Jul 31.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/19719
Publisher Site
http://dx.doi.org/10.18632/oncotarget.19719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642571PMC
September 2017

Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.

PLoS One 2017 13;12(1):e0170081. Epub 2017 Jan 13.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170081PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234813PMC
August 2017

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.

Clin Cancer Res 2017 Aug 2;23(16):4780-4792. Epub 2017 May 2.

Section of Translational Breast Cancer Research, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559319PMC
August 2017

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.

Breast Cancer Res 2017 Aug 15;19(1):93. Epub 2017 Aug 15.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-017-0878-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557476PMC
August 2017

Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.

Breast Cancer Res Treat 2017 Jul 17;164(1):57-67. Epub 2017 Apr 17.

Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4233-5
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4233-5DOI Listing
July 2017

Mammographic breast density is associated with the development of contralateral breast cancer.

Cancer 2017 06 30;123(11):1935-1940. Epub 2017 Jan 30.

Division of Cancer Medicine, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.30573
Publisher Site
http://dx.doi.org/10.1002/cncr.30573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577931PMC
June 2017

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy.

Br J Cancer 2017 Feb 12;116(4):509-514. Epub 2017 Jan 12.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318977PMC
February 2017

Value of routine staging imaging studies for patients with stage III breast cancer.

J Surg Oncol 2016 Dec 19;114(8):917-921. Epub 2016 Sep 19.

Department of Hematology/Oncology, Louisiana State University, New Orleans, Louisiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24436DOI Listing
December 2016

Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.

Breast Cancer Res Treat 2016 11 23;160(1):101-109. Epub 2016 Sep 23.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3986-6DOI Listing
November 2016

T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.

J Clin Oncol 2016 10;34(29):3511-3517

Hannah Dzimitrowicz, Annette Hood, Osama Abdelghany, Christos Hatzis, and Lajos Pusztai, Yale University School of Medicine, New Haven, CT; Michael Berger and Craig Vargo, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH; and Akshara Singareeka Raghavendra, Debu Tripathy, Vicente Valero, and Rashmi Murthy, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075965PMC
October 2016

Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes.

Ann Surg Oncol 2016 08 15;23(8):2385-90. Epub 2016 Mar 15.

Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5184-5DOI Listing
August 2016

Phosphorylated ribosomal S6 (p-rpS6) as a post-treatment indicator of HER2 signalling targeted drug resistance.

Biomarkers 2015 ;20(5):313-22

a Department of Medicine , Norris Comprehensive Cancer Center, University of Southern California , Los Angeles , CA , USA .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/1354750X.2015.1068865DOI Listing
June 2016

Highlights of the 2015 San Antonio Breast Cancer Symposium.

Genes Dis 2016 Jun 25;3(2):110-113. Epub 2016 Mar 25.

Georgia Regents University Cancer Center, 1411 Laney Walker Blvd., Augusta, GA 30912, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523042163000
Publisher Site
http://dx.doi.org/10.1016/j.gendis.2016.03.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146180PMC
June 2016

Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer.

Breast Cancer Res Treat 2016 06 4;157(2):339-350. Epub 2016 May 4.

The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3815-yDOI Listing
June 2016

Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.

Ann Surg Oncol 2016 May 17;23(5):1515-21. Epub 2015 Dec 17.

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-5020-3DOI Listing
May 2016

Symptom burden and quality of life among women with HER2(+) metastatic breast cancer.

Breast J 2015 Mar-Apr;21(2):208-10. Epub 2015 Feb 6.

AdvancedBC.org, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12374DOI Listing
December 2015

Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases.

Mol Cancer Ther 2015 Dec 6;14(12):2687-99. Epub 2015 Oct 6.

Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674309PMC
December 2015

Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.

Cancer Prev Res (Phila) 2015 Oct 14;8(10):942-51. Epub 2015 Aug 14.

Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596769PMC
October 2015

Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy.

Breast Cancer Res Treat 2015 Sep 14;153(2):417-23. Epub 2015 Aug 14.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-015-3533
Web Search
http://link.springer.com/10.1007/s10549-015-3533-x
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3533-xDOI Listing
September 2015

The BMC Medicine breast cancer collection: an illustration of contemporary research and clinical care.

Authors:
Debu Tripathy

BMC Med 2015 Sep 23;13:223. Epub 2015 Sep 23.

The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1354, Houston, 77030, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-015-0474-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580146PMC
September 2015

Personalizing management of patients at elevated breast cancer risk: where do we start?

Authors:
Debu Tripathy

Breast J 2014 Nov-Dec;20(6):569-70. Epub 2014 Sep 25.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12350DOI Listing
June 2015

Malignancy rates after surgical excision of discordant breast biopsies.

J Surg Res 2015 May 27;195(1):152-7. Epub 2014 Nov 27.

Department of Surgery, Section of Breast and Soft Tissue Surgery, USC Norris Comprehensive Cancer Center, Los Angeles, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2014.11.032DOI Listing
May 2015

Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital.

J Oncol Pract 2015 Mar 20;11(2):e163-9. Epub 2015 Jan 20.

Los Angeles County and University of Southern California Healthcare Network; University of Southern California, Keck School of Medicine; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles; and Ventura County Medical System, Ventura, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2014.001529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371122PMC
March 2015

Integrative oncology - strong science is needed for better patient care.

Nat Rev Cancer 2015 Mar 19;15(3):165. Epub 2015 Feb 19.

1] Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. [2] Society for Integrative Oncology, S.Z. currently serves as the President, and all other authors are Past Presidents of the Society.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3822-c1DOI Listing
March 2015

Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

J Natl Cancer Inst Monogr 2014 Nov;2014(50):346-58

Department of Epidemiology, Mailman School of Public Health (HG, DH), Herbert Irving Comprehensive Cancer Center, (HG, DH), and Department of Medicine, College of Physicians and Surgeons (DH), Columbia University, New York, NY (HG, DH); School of Nursing, University of British Columbia, Vancouver, BC, Canada (LGB); Department of Oncology, University of Calgary, Calgary, AB, Canada (LEC); Institute for Health and Aging, University of California San Francisco, CA (MC); Chicken Soup Chinese Medicine, San Francisco, CA (MC); Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY (GD); Harbin Clinic, Rome, GA (MM); Gemini Group, Ann Arbor, MI (JP); Ottawa Integrative Cancer Center, Ottawa, ON, Canada (DS); Canadian College of Naturopathic Medicine, Toronto, ON, Canada (DS); Department of Family Medicine, University of Michigan Health System (AS, SMZ), Department of Environmental Health Sciences, School of Public Health (SMZ), and Department of Biostatistics (AS), University of Michigan, Ann Arbor, MI (AS, SMZ); Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (DT).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411539PMC
November 2014

Immunoconjugates in the treatment of breast cancer.

Authors:
Debu Tripathy

Clin Adv Hematol Oncol 2014 Jul;12(7):469-72

University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
July 2014

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer.

Breast Cancer Res Treat 2014 Jun 6;145(3):725-34. Epub 2014 Apr 6.

Sarah Cannon Research Institute, 250 25th Avenue N, Suite 100, Nashville, TN, 37203, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2916-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031392PMC
June 2014